Cargando…
Overcoming acquired resistance to cancer immune checkpoint therapy: potential strategies based on molecular mechanisms
Immune checkpoint inhibitors (ICIs) targeting CTLA-4 and PD-1/PD-L1 to boost tumor-specific T lymphocyte immunity have opened up new avenues for the treatment of various histological types of malignancies, with the possibility of durable responses and improved survival. However, the development of a...
Autores principales: | Wang, Bin, Han, Yin, Zhang, Yuyu, Zhao, Qin, Wang, Huanhuan, Wei, Jinlong, Meng, Lingbin, Xin, Ying, Jiang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311815/ https://www.ncbi.nlm.nih.gov/pubmed/37386520 http://dx.doi.org/10.1186/s13578-023-01073-9 |
Ejemplares similares
-
Sulforaphane-Mediated Nrf2 Activation Prevents Radiation-Induced Skin Injury through Inhibiting the Oxidative-Stress-Activated DNA Damage and NLRP3 Inflammasome
por: Wei, Jinlong, et al.
Publicado: (2021) -
Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma
por: Wang, Huanhuan, et al.
Publicado: (2020) -
Radiation-Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms
por: Wei, Jinlong, et al.
Publicado: (2019) -
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
por: Zhou, Xiaoting, et al.
Publicado: (2022) -
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
por: Wang, Bin, et al.
Publicado: (2021)